Cargando…
The deficiency of adenosine deaminase type 2-results of therapeutic intervention
Autores principales: | Ombrello, A, Stone, D, Hoffmann, P, Jones, A, Barham, B, Barron, K, Flegel, W, Sheldon, S, Zhou, Q, Hershfield, M, Aksentijevich, I, Kumar, P, Kastner, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597175/ http://dx.doi.org/10.1186/1546-0096-13-S1-O40 |
Ejemplares similares
-
Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)
por: Barron, K, et al.
Publicado: (2015) -
OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
por: Zhou, Q, et al.
Publicado: (2013) -
Immune dysregulation in patients with TRNT1 deficiency
por: Giannelou, A, et al.
Publicado: (2015) -
TRNT1 missense mutations define an autoinflammatory disease characterized by recurrent fever, severe anemia, and b-cell immunodeficiency
por: Aksentijevich, Ivona, et al.
Publicado: (2014) -
A dominantly-inherited Behcet-like disorder caused by haploinsufficiency of the TNFAIP3/A20 protein
por: Zhou, Q, et al.
Publicado: (2015)